{"pmid":32437642,"title":"Prevalence of obesity among adult inpatients with COVID-19 in France.","text":["Prevalence of obesity among adult inpatients with COVID-19 in France.","Lancet Diabetes Endocrinol","Caussy, Cyrielle","Pattou, Francois","Wallet, Florent","Simon, Chantal","Chalopin, Sarah","Telliam, Charlene","Mathieu, Daniel","Subtil, Fabien","Frobert, Emilie","Alligier, Maud","Delaunay, Dominique","Vanhems, Philippe","Laville, Martine","Jourdain, Merce","Disse, Emmanuel","32437642"],"journal":"Lancet Diabetes Endocrinol","authors":["Caussy, Cyrielle","Pattou, Francois","Wallet, Florent","Simon, Chantal","Chalopin, Sarah","Telliam, Charlene","Mathieu, Daniel","Subtil, Fabien","Frobert, Emilie","Alligier, Maud","Delaunay, Dominique","Vanhems, Philippe","Laville, Martine","Jourdain, Merce","Disse, Emmanuel"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437642","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/S2213-8587(20)30160-1","locations":["France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667521393637457922,"score":9.490897,"similar":[{"pmid":32377709,"title":"Obesity a risk factor for increased COVID19 prevalence, severity and lethality (Review).","text":["Obesity a risk factor for increased COVID19 prevalence, severity and lethality (Review).","Coronaviruses (CoVs), enveloped positive-sense RNA viruses, are a group of viruses that cause infections in the human respiratory tract, which can be characterized clinically from mild to fatal. The severe acute respiratory syndrome coronavirus 2 (SARSCoV2) is the virus responsible. The global spread of COVID19 can be described as the worst pandemic in humanity in the last century. To date, COVID19 has infected more than 3,000,000 people worldwide and killed more than 200,000 people. All age groups can be infected from the virus, but more serious symptoms that can possibly result in death are observed in older people and those with underlying medical conditions such as cardiovascular and pulmonary disease. Novel data report more severe symptoms and even a negative prognosis for the obese patients. A growing body of evidence connects obesity with COVID19 and a number of mechanisms from immune system activity attenuation to chronic inflammation are implicated. Lipid peroxidation creates reactive lipid aldehydes which in a patient with metabolic disorder and COVID19 will affect its prognosis. Finally, pregnancyassociated obesity needs to be studied further in connection to COVID19 as this infection could pose high risk both to pregnant women and the fetus.","Mol Med Rep","Petrakis, Demetrios","Margina, Denisa","Tsarouhas, Konstantinos","Tekos, Fotios","Stan, Miriana","Nikitovic, Dragana","Kouretas, Demetrios","Spandidos, Demetrios A","Tsatsakis, Aristidis","32377709"],"abstract":["Coronaviruses (CoVs), enveloped positive-sense RNA viruses, are a group of viruses that cause infections in the human respiratory tract, which can be characterized clinically from mild to fatal. The severe acute respiratory syndrome coronavirus 2 (SARSCoV2) is the virus responsible. The global spread of COVID19 can be described as the worst pandemic in humanity in the last century. To date, COVID19 has infected more than 3,000,000 people worldwide and killed more than 200,000 people. All age groups can be infected from the virus, but more serious symptoms that can possibly result in death are observed in older people and those with underlying medical conditions such as cardiovascular and pulmonary disease. Novel data report more severe symptoms and even a negative prognosis for the obese patients. A growing body of evidence connects obesity with COVID19 and a number of mechanisms from immune system activity attenuation to chronic inflammation are implicated. Lipid peroxidation creates reactive lipid aldehydes which in a patient with metabolic disorder and COVID19 will affect its prognosis. Finally, pregnancyassociated obesity needs to be studied further in connection to COVID19 as this infection could pose high risk both to pregnant women and the fetus."],"journal":"Mol Med Rep","authors":["Petrakis, Demetrios","Margina, Denisa","Tsarouhas, Konstantinos","Tekos, Fotios","Stan, Miriana","Nikitovic, Dragana","Kouretas, Demetrios","Spandidos, Demetrios A","Tsatsakis, Aristidis"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32377709","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3892/mmr.2020.11127","locations":["obese"],"e_drugs":["Lipids"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666262687697338368,"score":41.097298}]}